Inventor · disambiguated record
Wei Li
Also filed as: LI WEI · LI WEI VIVIAN
34 granted patents·30 pending applications·612 citations·filing 2003–2025
98Inventor score
Files withGENENTECH INC27TISSUETECH INC12TSENG SCHEFFER9BRINTON MARGO A2FUJIFILM ELECTRONIC MAT USA INC2
Top patents by PatentIndex Score
64 records- 0198US8182841B2Amniotic membrane preparations and purified compositions and anti-inflammation methodsTSENG SCHEFFER·Filed 2006·Granted May 22, 2012·68 cites·7 claims
- 0298US8182840B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTSENG SCHEFFER·Filed 2006·Granted May 22, 2012·66 cites·3 claims
- 0398US8153162B2Purified amniotic membrane compositions and methods of useTSENG SCHEFFER·Filed 2006·Granted Apr 10, 2012·98 cites·11 claims
- 0497US8460714B2Purified amniotic membrane compositions and methods of useTSENG SCHEFFER·Filed 2012·Granted Jun 11, 2013·43 cites·17 claims
- 0597US8455009B2Amniotic membrane preparations and purified compositions and anti-inflammation methodsTSENG SCHEFFER·Filed 2012·Granted Jun 4, 2013·39 cites·17 claims
- 0697US8440235B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTSENG SCHEFFER·Filed 2012·Granted May 14, 2013·41 cites·16 claims
- 0797US8187639B2Amniotic membrane preparations and purified compositions and anti-angiogenesis treatmentTSENG SCHEFFER·Filed 2006·Granted May 29, 2012·64 cites·7 claims
- 0896US9198939B2Purified amniotic membrane compositions and methods of useTISSUETECH INC·Filed 2013·Granted Dec 1, 2015·18 cites·14 claims
- 0996US9161955B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2013·Granted Oct 20, 2015·19 cites·12 claims
- 1096US8420126B2Amniotic membrane preparations and purified compositions and anti-angiogenesis treatmentTSENG SCHEFFER·Filed 2012·Granted Apr 16, 2013·41 cites·17 claims
- 1195US10632155B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2018·Granted Apr 28, 2020·5 cites·14 claims
- 1295US9956252B2Purified amniotic membrane compositions and methods of useTISSUETECH INC·Filed 2015·Granted May 1, 2018·10 cites·20 claims
- 1395US9161956B2Amniotic membrane preparations and purified compositions and anti-inflammation methodsTISSUETECH INC·Filed 2013·Granted Oct 20, 2015·16 cites·12 claims
- 1494US9750771B2Amniotic membrane preparations and purified compositions and anti-inflammation methodsTISSUETECH INC·Filed 2015·Granted Sep 5, 2017·8 cites·15 claims
- 1594US9724370B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2015·Granted Aug 8, 2017·8 cites·11 claims
- 1694US9161954B2Amniotic membrane preparations and purified compositions and anti-angiogenesis treatmentTISSUETECH INC·Filed 2013·Granted Oct 20, 2015·18 cites·12 claims
- 1792US10272119B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2017·Granted Apr 30, 2019·5 cites·13 claims
- 1892US9750772B2Amniotic membrane preparations and purified compositions and anti-angiogenesis treatmentTISSUETECH INC·Filed 2015·Granted Sep 5, 2017·9 cites·13 claims
- 1991US9346815B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2015·Granted May 24, 2016·5 cites·20 claims
- 2088US9604984B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2016·Granted Mar 28, 2017·4 cites·21 claims
- 2185US9266961B2Anti-PCSK9 antibodies, formulations, dosing, and methods of useGENENTECH INC·Filed 2013·Granted Feb 23, 2016·8 cites·42 claims
- 2285US7625835B2Photocatalyst and use thereofGM GLOBAL TECH OPERATIONS INC·Filed 2006·Granted Dec 1, 2009·13 cites·26 claims
- 2374US11155557B2Pyrazolopyrimidine compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 26, 2021·1 cites·19 claims
- 2473US9873709B2Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Granted Jan 23, 2018·1 cites·14 claims
- 2572US2022204517A1Inhaled powder formulationsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2671US9006192B2RNAi methods and compositions for stimulating proliferation of cells with adherent junctionsTSENG SCHEFFER·Filed 2007·Granted Apr 14, 2015·2 cites·20 claims
- 2770US2022024945A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2869US2019322661A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2967US12383554B2Compositions and methods to protect mammalian tissue against cold and other metabolic stressesTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2022·Granted Aug 12, 2025·0 cites·11 claims
- 3065US2025075036A1Aryl-bisimidazolium polymers and uses thereofIONOMR INNOVATIONS INC·Filed 2024·Application pending·0 cites
- 3165US2024350456A1Compositions and methods for diagnosing and treating inflammatory conditionsUNIV RUTGERS·Filed 2024·Application pending·0 cites
- 3264US11731943B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted Aug 22, 2023·0 cites·8 claims
- 3364US10787484B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2018·Granted Sep 29, 2020·0 cites·73 claims
- 3464US8303946B2Methods and compositions for inhibition of viral replicationBRINTON MARGO A·Filed 2003·Granted Nov 6, 2012·2 cites·8 claims
- 3564US2018305355A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3662US11034725B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2020·Granted Jun 15, 2021·0 cites·9 claims
- 3761US2020165260A1Inhaled powder formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 3860US2017145020A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3960US2019233441A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4059US2020062779A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4159US2024327761A1Cleaning compositions and methods of use thereofFUJIFILM ELECTRONIC MAT USA INC·Filed 2024·Application pending·0 cites
- 4259US2019337946A1Triazolopyridine compounds and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4357US11547708B2Compositions and methods to protect mammalian tissue against cold and other metabolic stressesUS HEALTH·Filed 2018·Granted Jan 10, 2023·0 cites·11 claims
- 4457US2025009832A1Composition for inhibiting proliferation of tumor comprising sanguisorba officinalis extract as effective componentKOREA INST ORIENTAL MEDICINE·Filed 2022·Application pending·0 cites
- 4557US2018298033A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4656US2018265515A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 4756US2018327402A1Triazolopyridine compounds and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 4856US2018334465A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 4954US2025257286A1Cleaning compositions and methods of use thereofFUJIFILM ELECTRONIC MAT USA INC·Filed 2025·Application pending·0 cites
- 5054US2007128719A1Isolation and expansion of animal cells in cell culturesTISSUETECH INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wei Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →